Net gamma exposure for Medpace Holdings Inc (MEDP) options was negative at the Nov 4, 2026 close, about $760.72K per 1% move in the stock. It has been positive on 2 of the last 20 trading days. With negative gamma, dealer hedging tends to follow price moves, which can make swings larger.
Upgrade to unlock Gamma Flip, Gamma Profile, Call Wall, Put Wall, and multiple expiration dates.
Gamma Exposure by Strike
Showing results for MEDP, 2026-11-20(m), calls & puts
Gamma Exposure Stats
Showing results for MEDP, 2026-11-20(m), calls & puts
Net Gamma Exposure by Expiration
Showing results for MEDP, 2026-11-20(m), calls & puts. View all expiries
| Expiration | Net GEX | Call GEX | Put GEX | Call Wall | Put Wall | Gamma Flip |
|---|
MEDP Gamma Exposure FAQ
What is gamma exposure (GEX)?
Gamma exposure estimates how much stock option dealers must buy or sell to stay hedged for each 1% move in the underlying.
Is MEDP gamma exposure positive or negative?
Medpace net gamma exposure was negative on Nov 4, 2026, at -$760.72K. It has been positive on 2 of the last 20 trading days.
How has MEDP gamma exposure changed recently?
Medpace net gamma exposure went from -$3.95M on Oct 7, 2026 to -$760.72K on Nov 4, 2026. See the MEDP gamma exposure history for a longer view.
What is Medpace Holdings Inc?
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms.